Nelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial

Nelonemdaz is a multitarget neuroprotectant that selectively blocks N-methyl-D-aspartate receptors and scavenges free radicals, as proven in preclinical ischemia-reperfusion studies. We aimed to evaluate the safety and efficacy of nelonemdaz in patients with acute ischemic stroke receiving endovascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Ji Man, Lee, Jin Soo, Lee, Yeong-Bae, Shin, Dong Hoon, Shin, Dong-Ick, Hwang, Yang-Ha, Ahn, Seong Hwan, Kim, Jae Guk, Sohn, Sung-Il, Kwon, Sun U., Lee, Ji Sung, Gwag, Byoung Joo, Chamorro, Ángel, Choi, Dennis W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586831/
https://www.ncbi.nlm.nih.gov/pubmed/36065810
http://dx.doi.org/10.1161/STROKEAHA.122.039649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586831/
https://www.ncbi.nlm.nih.gov/pubmed/36065810
http://dx.doi.org/10.1161/STROKEAHA.122.039649

Ejemplares similares